AVX502

BIOLOGICAL2 trials

Sponsors

AlphaVax, Inc.

Conditions

Influenza

Phase 1

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

CompletedNCT00440362

AlphaVax, Inc.Influenza

Start: 2007-04-30End: 2007-09-30Updated: 2008-11-10

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza

CompletedNCT00706732

AlphaVax, Inc.Influenza

Start: 2008-06-30End: 2009-03-31Updated: 2012-07-12